Clene director granted 4,752 stock options
Clene Inc. director Shalom Jacobovitz received a grant of stock options for 4,752 shares of common stock on August 13, 2026 under the Clene Inc. Amended 2020 Stock Plan.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Clene Inc. director Shalom Jacobovitz received a grant of stock options for 4,752 shares of common stock on August 13, 2026 under the Clene Inc. Amended 2020 Stock Plan. The options have an exercise price of $4.19 per share, vest immediately upon grant, and expire on August 12, 2036. Following this award, Jacobovitz holds 4,752 stock options directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | stock option F1 | 4,752 | $0.00 | $0.00 |
Footnotes (1)
- F1. This option was granted on August 13, 2026 as an option for 4,752 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.19 per share. The options vest immediately upon grant.
Key Figures
Key Terms
stock option financial
exercise price financial
vest immediately upon grant financial
Amended 2020 Stock Plan financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Clene Inc. (CLNN) director Shalom Jacobovitz receive in this Form 4 filing?
What is the exercise price of the stock options granted to Shalom Jacobovitz at Clene Inc. (CLNN)?
When do Shalom Jacobovitz’s Clene Inc. (CLNN) stock options vest and expire?
How many Clene Inc. (CLNN) stock options does Shalom Jacobovitz hold after this transaction?
Was the Clene Inc. (CLNN) Form 4 transaction made under a Rule 10b5-1 trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.